Published date: 5 November 2021

This notice was replaced on 5 November 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 5 November 2021)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Influenza vaccines - 33651660

Location of contract

SW1H 0EU

Value of contract

£0

Procurement reference

CF-0452400D0O000000rwimUAA1

Published date

5 November 2021

Closing date

17 September 2021

Closing time

12pm

Contract start date

7 October 2021

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

This Contract is for a centrally procured, additional supply of Flucelvax Tetra Quadrivalent Influenza Vaccine to ensure sufficient supply of flu vaccine for the 21/22 flu season

More information

Links

Award information

Awarded date

7 October 2021

Contract start date

7 October 2021

Contract end date

31 March 2022

Total value of contract

£7,455,000

This contract was awarded to 1 supplier.

Seqirus UK Limited

Address

Point 29 Market Street SL6 8AA

Reference

None

About the buyer

Contact name

Gillian Eglen

Address

Victoria Street
London
SW1H 0EU
GB

Email

gillian.eglen@dhsc.gov.uk